In accordance with our observations gained from an animal model of MS, the level of STING expression was downregulated in peripheral immune cells during the acute phases of RRMS in comparison to clinically stable RRMS patients and appropriately matched HD. The gene discussed is STING1; the disease is myeloid sarcoma.